BUL/THQM (BUL/THQM)

Bulgarian Stock Exchange: BUL/THQM · EUR

€8.80

+0.15 (+1.7%)· Recorded snapshot

Market cap	891.4M
Revenue (ttm)	36.4M
Net income (ttm)	3.1M
EPS (ttm)	€0.03
Shares out	101.3M
P/E (trailing)	286.6x
Volume	18,000
Beta	0.10

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 36.4M
Net income (ttm): 3.1M
EPS (ttm): €0.03
P/E (trailing): 286.6x
Market cap: 891.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E286.6

P25 n/aP50 n/aP75 n/a

ROE5.2

P25 n/aP50 n/aP75 n/a

ROIC4.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.6%

Nasdaq Composite-2.3%

Dow Jones Industrial Average+1.9%

Russell 2000+1.8%

All BUL/THQM indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

EUR

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Bulgaria
Country code	BG
Earnings date	2026-11-04
Employees	214
Employees change	-4
Employees growth	-1.83%
Enterprise value	EUR 896.4M
Exchange	Bulgarian Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1999
Industry	Pharmaceutical Preparations
Is primary listing	Yes
ISIN number	BG1100008074
Last earnings date	2026-01-27
Last refreshed	2026-10-29
Last stock split date	2026-07-07
Last stock split type	Forward
Market cap	EUR 891.4M
Next earnings date	2026-11-04
Price	EUR 8.80
Price currency	EUR
SIC code	2834
Stock price date	2026-10-20
Symbol	bul/THQM
Website	https://www.tchaikapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	730.2x
Average P/E ratio (3Y)	382.56x
Average P/E ratio (5Y)	787.27x
Earnings yield	0.35%
EV/Earnings	288.23x
EV/EBIT	261.9x
EV/EBITDA	168.64x
EV/FCF	566.92x
EV/Sales	24.61x
FCF / EV yield	0.18%
FCF yield	0.18%
Graham number	0.65036
Graham upside	-92.61%
Lynch fair value	EUR 0.77
Lynch upside	-91.28%
P/B ratio	14.37x
P/E ratio	286.64x
P/FCF ratio	563.78x
P/OCF ratio	458.45x
P/S ratio	24.48x
Price / tangible book value	14.84x
Price/EBITDA ratio	191.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.4%
EBITDA margin	12.76%
Effective tax rate	9.87%
FCF margin	4.34%
Gross margin	86.77%
Operating margin	9.4%
Pretax margin	9.48%
Profit margin	8.54%
Profit per employee	EUR 14,670
Revenue per employee	EUR 171,786
ROA	3.05%
ROA (5Y)	2.02%
ROCE	5.4%
ROE	5.16%
ROE (5Y)	3.4%
ROIC	4.62%
ROIC (5Y)	3.09%
Tax / revenue	0.94%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-4.41%
EPS growth (Q)	-57.7%
EPS growth (QoQ)	-69.06%
EPS growth 10Y	-3.2%
EPS growth 3Y	9.49%
EPS growth 5Y	84.09%
FCF growth	178.7%
FCF growth (Q)	-36%
FCF growth (QoQ)	-78.28%
FCF growth 3Y	45.76%
FCF growth 5Y	61.67%
Gross profit growth	53.71%
Gross profit growth (Q)	100.89%
Gross profit growth 3Y	23.38%
Gross profit growth 5Y	42.09%
Net income growth	-5.94%
Net income growth (Q)	-57.7%
Net income growth (QoQ)	-69.05%
Net income growth 3Y	10.71%
Net income growth 5Y	94.6%
OCF growth	36.78%
OCF growth (Q)	-42.53%
OCF growth (QoQ)	-69.88%
OCF growth 10Y	0.94%
OCF growth 3Y	6.49%
OCF growth 5Y	7.22%
Operating income growth	-6.98%
Operating income growth (Q)	-52.26%
Operating income growth 3Y	11.24%
Operating income growth 5Y	74.56%
Revenue growth	21.98%
Revenue growth (Q)	17.47%
Revenue growth (QoQ)	-1.01%
Revenue growth 10Y	8.49%
Revenue growth 3Y	15.49%
Revenue growth 5Y	11.8%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -363,277
Depreciation and amortization	EUR 1.2M
EBIT	EUR 3.4M
EBITDA	EUR 4.6M
EPS	EUR 0.03
FCF per share	EUR 0.02
Financing cash flow	EUR -1.6M
Free cash flow	EUR 1.6M
Gross profit	EUR 31.6M
Income taxes	EUR 340,618
Investing cash flow	EUR -363,277
Net borrowing	EUR -1.4M
Net cash flow	EUR 16,414
Net income	EUR 3.1M
Operating income	EUR 3.4M
Revenue	EUR 36.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	48.85
Book value per share	EUR 0.61
Debt / EBITDA	0.94
Debt / equity	0.08
Debt / FCF	3.17
Interest coverage	15.46
Long-term assets	EUR 21.8M
Long-term liabilities	EUR 1.4M
Net cash (debt)	EUR -5M
Net cash / market cap	-0.56%
Net debt / EBITDA	1.07
Net debt / equity	0.08
Net debt / FCF	3.14
Piotroski F-Score	5
Property, plant and equipment	EUR 17.2M
Shareholders' equity	EUR 62M
Tangible book value	EUR 60.1M
Tangible book value per share	EUR 0.59
Total assets	EUR 73M
Total cash	EUR 56,000
Total debt	EUR 5M
Total liabilities	EUR 11M
WACC	4.81%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.52
Current assets	EUR 51.2M
Current liabilities	EUR 9.6M
Current ratio	5.34
Inventory turnover	0.55
Net working capital	EUR 46M
Quick ratio	4.12
Working capital	EUR 41.6M
Working capital turnover	0.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.61%
Shareholder yield	1.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	362.43%
10Y return CAGR	16.55%
10Y total return	362.54%
150-day SMA	EUR 8.13
1D price change	1.73%
1M price change	12.1%
1M total return	12.1%
1W price change	2.33%
1W total return	2.33%
1Y price change	2.72%
1Y return CAGR	2.72%
1Y total return	2.72%
20-day SMA	EUR 7.55
200-day SMA	EUR 8.13
3M price change	7.32%
3M total return	7.32%
3Y price change	11.76%
3Y return CAGR	3.78%
3Y total return	11.76%
50-day SMA	EUR 8.06
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 9.04
52-week high date	2026-04-30
52-week low	EUR 5.60
52-week low date	2026-08-07
5Y price change	38.61%
5Y return CAGR	6.75%
5Y total return	38.6%
6M price change	-0.05%
6M total return	-0.05%
All-time high	EUR 9.04
All-time high date	2026-04-30
All-time low	EUR 1.10
All-time low date	2015-05-21
Average true range (ATR)	EUR 0.70
Average volume	2.2K
Beta (1Y)	-0.03
Beta (2Y)	0.06
Beta (5Y)	0.1
Change from 52-week high	-2.67%
Change from 52-week low	57.14%
Change from all-time high	-2.67%
Change from all-time low	700%
Change from open	1.73%
Day's gap	0%
Dollar volume	EUR 158,400
High price	EUR 8.80
Low price	EUR 8.65
Monthly RSI	55.48
Open price	EUR 8.65
Position in 52-week range	100%
Previous close	EUR 8.65
Price vs 150-day SMA	8.23%
Price vs 20-day SMA	16.6%
Price vs 200-day SMA	8.27%
Price vs 50-day SMA	9.25%
Relative volume	8.18
RSI	64.74
Sharpe ratio	0.42
Sharpe ratio (3Y)	0.49
Sharpe ratio (5Y)	1
Sortino ratio	0.69
Sortino ratio (3Y)	0.86
Sortino ratio (5Y)	1.68
Volume	18K
Weekly RSI	57.3
YTD price change	-1.06%
YTD total return	-1.06%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5.1M
Shares change (QoQ)	0%
Shares change (YoY)	-1.61%
Shares held by insiders	88.09%
Shares outstanding	101.3M

Deeper analysis on BUL/THQM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BUL/THQM report

Is a complete BUL/THQM research report available?

No complete published report is available for bul/THQM (BUL/THQM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

891.4M

Revenue (ttm)

36.4M

Net income (ttm)

3.1M

EPS (ttm)

€0.03

Shares out

101.3M

P/E (trailing)

286.6x

Volume

18,000

Beta

0.10

Metric

Value

Amount currency

EUR

Country

Bulgaria

Country code

Earnings date

2026-11-04

Employees

214

Employees change

-4

Employees growth

-1.83%

Enterprise value

EUR 896.4M

Exchange

Bulgarian Stock Exchange

Financial currency

EUR

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1999

Industry

Pharmaceutical Preparations

Is primary listing

Yes

ISIN number

BG1100008074

Last earnings date

2026-01-27

Last refreshed

2026-10-29

Last stock split date

2026-07-07

Last stock split type

Forward

Market cap

EUR 891.4M

Next earnings date

2026-11-04

Price

EUR 8.80

Price currency

EUR

SIC code

2834

Stock price date

2026-10-20

Symbol

bul/THQM

Website

https://www.tchaikapharma.com

Metric

Value

Average P/E ratio (10Y)

730.2x

Average P/E ratio (3Y)

382.56x

Average P/E ratio (5Y)

787.27x

Earnings yield

0.35%

EV/Earnings

288.23x

EV/EBIT

261.9x

EV/EBITDA

168.64x

EV/FCF

566.92x

EV/Sales

24.61x

FCF / EV yield

0.18%

FCF yield

0.18%

Graham number

0.65036

Graham upside

-92.61%

Lynch fair value

EUR 0.77

Lynch upside

-91.28%

P/B ratio

14.37x

P/E ratio

286.64x

P/FCF ratio

563.78x

P/OCF ratio

458.45x

P/S ratio

24.48x

Price / tangible book value

14.84x

Price/EBITDA ratio

191.89x

Metric

Value

EBIT margin

9.4%

EBITDA margin

12.76%

Effective tax rate

9.87%

FCF margin

4.34%

Gross margin

86.77%

Operating margin

9.4%

Pretax margin

9.48%

Profit margin

8.54%

Profit per employee

EUR 14,670

Revenue per employee

EUR 171,786

ROA

3.05%

ROA (5Y)

2.02%

ROCE

5.4%

ROE

5.16%

ROE (5Y)

3.4%

ROIC

4.62%

ROIC (5Y)

3.09%

Tax / revenue

0.94%

Metric

Value

EPS growth

-4.41%

EPS growth (Q)

-57.7%

EPS growth (QoQ)

-69.06%

EPS growth 10Y

-3.2%

EPS growth 3Y

9.49%

EPS growth 5Y

84.09%

FCF growth

178.7%

FCF growth (Q)

-36%

FCF growth (QoQ)

-78.28%

FCF growth 3Y

45.76%

FCF growth 5Y

61.67%

Gross profit growth

53.71%

Gross profit growth (Q)

100.89%

Gross profit growth 3Y

23.38%

Gross profit growth 5Y

42.09%

Net income growth

-5.94%

Net income growth (Q)

-57.7%

Net income growth (QoQ)

-69.05%

Net income growth 3Y

10.71%

Net income growth 5Y

94.6%

OCF growth

36.78%

OCF growth (Q)

-42.53%

OCF growth (QoQ)

-69.88%

OCF growth 10Y

0.94%

OCF growth 3Y

6.49%

OCF growth 5Y

7.22%

Operating income growth

-6.98%

Operating income growth (Q)

-52.26%

Operating income growth 3Y

11.24%

Operating income growth 5Y

74.56%

Revenue growth

21.98%

Revenue growth (Q)

17.47%

Revenue growth (QoQ)

-1.01%

Revenue growth 10Y

8.49%

Revenue growth 3Y

15.49%

Revenue growth 5Y

11.8%

Metric

Value

Capital expenditures

EUR -363,277

Depreciation and amortization

EUR 1.2M

EBIT

EUR 3.4M

EBITDA

EUR 4.6M

EPS

EUR 0.03

FCF per share

EUR 0.02

Financing cash flow

EUR -1.6M

Free cash flow

EUR 1.6M

Gross profit

EUR 31.6M

Income taxes

EUR 340,618

Investing cash flow

EUR -363,277

Net borrowing

EUR -1.4M

Net cash flow

EUR 16,414

Net income

EUR 3.1M

Operating income

EUR 3.4M

Revenue

EUR 36.4M

Metric

Value

Altman Z-Score

48.85

Book value per share

EUR 0.61

Debt / EBITDA

0.94

Debt / equity

0.08

Debt / FCF

3.17

Interest coverage

15.46

Long-term assets

EUR 21.8M

Long-term liabilities

EUR 1.4M

Net cash (debt)

EUR -5M

Net cash / market cap

-0.56%

Net debt / EBITDA

1.07

Net debt / equity

0.08

Net debt / FCF

3.14

Piotroski F-Score

Property, plant and equipment

EUR 17.2M

Shareholders' equity

EUR 62M

Tangible book value

EUR 60.1M

Tangible book value per share

EUR 0.59

Total assets

EUR 73M

Total cash

EUR 56,000

Total debt

EUR 5M

Total liabilities

EUR 11M

WACC

4.81%

Metric

Value

Asset turnover

0.52

Current assets

EUR 51.2M

Current liabilities

EUR 9.6M

Current ratio

5.34

Inventory turnover

0.55

Net working capital

EUR 46M

Quick ratio

4.12

Working capital

EUR 41.6M

Working capital turnover

0.91

Metric

Value

Buyback yield / dilution

1.61%

Shareholder yield

1.61%

Metric

Value

10Y price change

362.43%

10Y return CAGR

16.55%

10Y total return

362.54%

150-day SMA

EUR 8.13

1D price change

1.73%

1M price change

12.1%

1M total return

12.1%

1W price change

2.33%

1W total return

2.33%

1Y price change

2.72%

1Y return CAGR

2.72%

1Y total return

2.72%

20-day SMA

EUR 7.55

200-day SMA

EUR 8.13

3M price change

7.32%

3M total return

7.32%

3Y price change

11.76%

3Y return CAGR

3.78%

3Y total return

11.76%

50-day SMA

EUR 8.06

50-day SMA vs 200-day SMA

50under200

52-week high

EUR 9.04

52-week high date

2026-04-30

52-week low

EUR 5.60

52-week low date

2026-08-07

5Y price change

38.61%

5Y return CAGR

6.75%

5Y total return

38.6%

6M price change

-0.05%

6M total return

-0.05%

All-time high

EUR 9.04

All-time high date

2026-04-30

All-time low

EUR 1.10

All-time low date

2015-05-21

Average true range (ATR)

EUR 0.70

Average volume

2.2K

Beta (1Y)

-0.03

Beta (2Y)

0.06

Beta (5Y)

0.1

Change from 52-week high

-2.67%

Change from 52-week low

57.14%

Change from all-time high

-2.67%

Change from all-time low

700%

Change from open

1.73%

Day's gap

Dollar volume

EUR 158,400

High price

EUR 8.80

Low price

EUR 8.65

Monthly RSI

55.48

Open price

EUR 8.65

Position in 52-week range

100%

Previous close

EUR 8.65

Price vs 150-day SMA

8.23%

Price vs 20-day SMA

16.6%

Price vs 200-day SMA

8.27%

Price vs 50-day SMA

9.25%

Relative volume

8.18

RSI

64.74

Sharpe ratio

0.42

Sharpe ratio (3Y)

0.49

Sharpe ratio (5Y)

Sortino ratio

0.69

Sortino ratio (3Y)

0.86

Sortino ratio (5Y)

1.68

Volume

18K

Weekly RSI

57.3

YTD price change

-1.06%

YTD total return

-1.06%

Metric

Value

Float

5.1M

Shares change (QoQ)

Shares change (YoY)

-1.61%

Shares held by insiders

88.09%

Shares outstanding

101.3M

BUL/THQM (BUL/THQM)

Price

Financial snapshot

Fair-value bridge

Latest news · BUL/THQM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BUL/THQM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BUL/THQM

Frequently asked questions

BUL/THQM (BUL/THQM)

Price

Financial snapshot

Fair-value bridge

Latest news · BUL/THQM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BUL/THQM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BUL/THQM

Frequently asked questions